Article: Enterococcus cecorum Empyema Thoracis Successfully Treated with Cefotaxime

File Download Links for fulltext
(May Require Subscription)
Supplementary
  • Basic View
  • Metadata View
  • XML View
TitleEnterococcus cecorum Empyema Thoracis Successfully Treated with Cefotaxime
AuthorsWoo, PCY1
Tam, DMW1
Lau, SKP1
Fung, AMY1
Yuen, KY1
Issue Date2004
PublisherAmerican Society for Microbiology.
CitationJournal Of Clinical Microbiology, 2004, v. 42 n. 2, p. 919-922 [How to Cite?]
DOI: http://dx.doi.org/10.1128/JCM.42.2.919-922.2004
AbstractWe report the first case of Enterococcus cecorum empyema thoracis and spontaneous bacterial peritonitis in a 44-year-old man with underlying cirrhosis. The patient responded to cefotaxime (MIC, 0.25 μg/ml) treatment and drainage of the empyema. Susceptibility of E. cecorum to expanded-spectrum cephalosporins could be due to its production of types of penicillin-binding proteins similar to those produced by Streptococcus species rather than to those produced by Enterococcus species (as predicted by phylogenetic analysis of the 16S rRNA gene sequences).
ISSN0095-1137
2011 Impact Factor: 4.153
2011 SCImago Journal Rankings: 0.397
DOIhttp://dx.doi.org/10.1128/JCM.42.2.919-922.2004
ISI Accession Number IDWOS:000189379000086
PubMed Central IDPMC344503
ReferencesReferences in Scopus
DC Field
Value
dc.contributor.authorWoo, PCY
dc.contributor.authorTam, DMW
dc.contributor.authorLau, SKP
dc.contributor.authorFung, AMY
dc.contributor.authorYuen, KY
dc.date.accessioned2008-06-12T06:37:28Z
dc.date.available2008-06-12T06:37:28Z
dc.date.issued2004
dc.description.abstractWe report the first case of Enterococcus cecorum empyema thoracis and spontaneous bacterial peritonitis in a 44-year-old man with underlying cirrhosis. The patient responded to cefotaxime (MIC, 0.25 μg/ml) treatment and drainage of the empyema. Susceptibility of E. cecorum to expanded-spectrum cephalosporins could be due to its production of types of penicillin-binding proteins similar to those produced by Streptococcus species rather than to those produced by Enterococcus species (as predicted by phylogenetic analysis of the 16S rRNA gene sequences).
dc.description.naturepublished_or_final_version
dc.format.extent386 bytes
dc.format.mimetypetext/html
dc.identifier.citationJournal Of Clinical Microbiology, 2004, v. 42 n. 2, p. 919-922 [How to Cite?]
DOI: http://dx.doi.org/10.1128/JCM.42.2.919-922.2004
dc.identifier.doihttp://dx.doi.org/10.1128/JCM.42.2.919-922.2004
dc.identifier.epage922
dc.identifier.hkuros87957
dc.identifier.isiWOS:000189379000086
dc.identifier.issn0095-1137
2011 Impact Factor: 4.153
2011 SCImago Journal Rankings: 0.397
dc.identifier.issue2
dc.identifier.openurl
dc.identifier.pmcidPMC344503
dc.identifier.pmid14766891
dc.identifier.scopuseid_2-s2.0-1242269290
dc.identifier.spage919
dc.identifier.urihttp://hdl.handle.net/10722/49244
dc.identifier.volume42
dc.languageeng
dc.publisherAmerican Society for Microbiology.
dc.publisher.placeUnited States
dc.relation.ispartofJournal of Clinical Microbiology
dc.relation.referencesReferences in Scopus
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License
dc.rightsJournal of Clinical Microbiology. Copyright © American Society for Microbiology.
dc.rightsCopyright © American Society for Microbiology, Journal of Clinical Microbiology, 2004, v. 42 n. 2, p. 919-922
dc.subject.meshAnti-Bacterial Agents - therapeutic use
dc.subject.meshCefotaxime - therapeutic use
dc.subject.meshEnterococcus - classification - drug effects - isolation & purification
dc.subject.meshGram-Positive Bacterial Infections - diagnosis - drug therapy
dc.subject.meshAsian Continental Ancestry Group
dc.titleEnterococcus cecorum Empyema Thoracis Successfully Treated with Cefotaxime
dc.typeArticle
Author Affiliations
  1. The University of Hong Kong